Gregory M. Glenn
2012
In 2012, Gregory M. Glenn earned a total compensation of $583.2K as SVP & Chief Medical Officer at Novavax, a 7% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $116,691 |
|---|---|
| Option Awards | $102,165 |
| Salary | $362,349 |
| Other | $1,972 |
| Total | $583,177 |
Glenn received $362.3K in salary, accounting for 62% of the total pay in 2012.
Glenn also received $116.7K in non-equity incentive plan, $102.2K in option awards and $2K in other compensation.
Rankings
In 2012, Gregory M. Glenn's compensation ranked 8,239th out of 11,487 executives tracked by ExecPay. In other words, Glenn earned more than 28.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,239 out of 11,487 | 28th |
Division Manufacturing | 2,975 out of 4,252 | 30th |
Major group Chemicals And Allied Products | 790 out of 1,200 | 34th |
Industry group Drugs | 565 out of 922 | 39th |
Industry Biological Products, Except Diagnostic Substances | 95 out of 165 | 42nd |
Source: SEC filing on April 30, 2013.
Glenn's colleagues
We found four more compensation records of executives who worked with Gregory M. Glenn at Novavax in 2012.